GI Oncology

Patrick DalyColorectal Cancer | September 20, 2023
Maintenance with cetuximab monotherapy appeared to improve PFS and OS in patients with metastatic colorectal cancer.
Read More
Rebecca AraujoColorectal Cancer | September 14, 2023
A systematic review reported that immune checkpoint inhibitor therapy shows promising results in metastatic CRC.
Rebecca AraujoPancreatic Cancer | September 8, 2023
Nimotuzumab plus gemcitabine demonstrated a favorable safety profile in patients with metastatic pancreatic cancer.
Rob DillardColorectal Cancer | September 5, 2023
The rate of colorectal cancer (CRC) screenings decreased by more than 20% during the COVID-19 pandemic.
Patrick DalyGEP-NETs | September 1, 2023
A study found key tumor heterogeneities, including Ki-67 indices, might contribute to disease progression in GEP-NETs.
Pranob BhattacharyaGastric Cancer | September 1, 2023
Pranob Bhattacharya discusses zolbetuximab, a first-in-class investigational therapy for the treatment of gastric cancer.
Oncology BrothersOncology Brothers | August 31, 2023
The Oncology Brothers speak with Cathy Eng, MD, about treatment of metastatic colorectal cancer with fruquintinib.
Rob DillardPancreatic Cancer | August 31, 2023
Results from a recent study suggest a novel therapy that may effectively treat pancreatic ductal adenocarcinoma.
Rebecca AraujoGI Cancer | August 29, 2023
Daily vitamin D3 supplementation was associated with reduced risk of relapse or death in digestive tract cancer.
Cailin ConnerEsophageal Cancer | August 28, 2023
An analysis found that esophageal cancer rates have declined in the United States since 2004.
Patrick DalyGEP-NETs | August 25, 2023
Lu-177-dotatate in PRRT appeared to treat GEP-NETs, though prior internal radiation may impede responses or worsen survival.
Rob DillardGI Cancer | August 23, 2023
Researchers identified a circRNA signature as a potential biomarker for GEP-NETs.
Rebecca AraujoGastric Cancer | August 17, 2023
A study evaluated the predictive ability of the combined SMI and PNI to assess survival in advanced gastric cancer patients.
Rebecca AraujoColorectal Cancer | August 14, 2023
Treatment with avelumab improved progression-free survival in patients with mCRC.
Cailin ConnerColorectal Cancer | August 11, 2023
Patients diagnosed with colorectal liver metastases in expert hospitals receive better treatment.
Rebecca AraujoEsophageal Cancer | August 10, 2023
Preoperative induction chemotherapy followed by chemoradiotherapy prior to esophagectomy does not improve survival.
Rebecca AraujoGastric Cancer | August 9, 2023
A study found that adding docetaxel to S-1 as postoperative chemotherapy improves survival in gastric cancer patients.
Rebecca AraujoGI Cancer | August 7, 2023
A study investigated whether BMI is related to postoperative opioid use after treatment for peritoneal carcinomatosis.
Rob DillardGI Cancer | August 4, 2023
Patients with advanced stage gastroenteropancreatic neuroendocrine tumors appear to benefit from PRRT.
Rob DillardEsophageal Cancer | August 2, 2023
Researchers assessed whether the aggressive warming of core body temperature reduces complications in esophageal cancer.
Latest News

September 22, 2023